Despite lingering perceptions otherwise, surgery for chronic thromboembolic pulmonary hypertension isn’t too risky just because pulmonary artery pressures are high. Here’s a case in point.
Dyspnea and related symptoms suggesting pulmonary embolism should also raise suspicion for possible chronic thromboembolic pulmonary hypertension. In this video, a multidisciplinary panel walks through considerations in differentiating the conditions and finding the best treatment strategy.
A recent study compared levels of HDL-C in CTEPH patients with those found in PAH patients and controls and assessed the association between HDL-C and markers of disease severity and survival.
Up to 40 percent of patients with chronic thromboembolic pulmonary hypertension aren’t eligible for surgery. For them, balloon pulmonary angioplasty is emerging as a highly promising new therapy.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The good news about chronic thromboembolic pulmonary hypertension (CTEPH)? Surgery is curative in over 90 percent of cases. The bad news? Physicians need to get a lot better at spotting it.
While the incidence of CTEPH is low, diagnosis is important by a specialized multidisciplinary program that can provide a surgical cure.
Pulmonary thromboendarterectomy provides significantly prolonged life expectancy for heart-lung transplant patient at Cleveland Clinic.